Acute Kidney Injury, Bronchopulmonary Dysplasia, and Urinary Biomarkers of Angiogenesis in Extremely Premature Neonates

Saturday, April 23, 2022

4:30 PM – 4:45 PM US MT

Location: Convention Center: Mile High Ballroom 3AB

CE: Enduring CME: 0.25

Publication Number: 1635.5

Michelle Starr, Indiana University School of Medicine and Riley Hospital for Children, Indianapolis, IN, United States; Robert H. Schmicker, University of Washington, Seattle, WA, United States; Brian A. Halloran, University of Alabama at Birmingham, Birmingham, AL, United States; Patrick Heagerty, University of Washington, Seattle, WA, United States; Patrick D. Brophy, Golisano Children's Hospital at The University of Rochester Medical Center, Pittsford, NY, United States; Stuart L. Goldstein, Cincinnati Children's Hospital, Cincinnati, OH, United States; Sandra E. Juul, University of Washington, Seattle, WA, United States; Sangeeta Hingorani, University of Washington/Seattle Childrens, Seattle, WA, United States; David Askenazi, UAB, Birmingham, AL, United States

Presenting Author(s)

Michelle C. Starr, MD MPH (she/her/hers)
Assistant Professor of Pediatrics
Indiana University School of Medicine
Indinapolis, IN, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Michelle Starr, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Robert H. Schmicker, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Brian A. Halloran, BS+MS Biology: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Patrick Heagerty, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Patrick D. Brophy, Md: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Stuart L. Goldstein, MD: ● Baxter, Inc (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness).
● BioPorto Diagnostics, Inc (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant).
● ExThera, Inc (Currently Ongoing) (Products/Services: Contractor including contracted research).
● Mallinckrodt, Inc (Ended In the Past 24 Months) (Products/Services: Advisory Committee).
● MediBeacon, Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Medtronic (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness).
● Nuwellis, Inc (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant).
● Otsuka (Currently Ongoing) (Products/Services: Advisory Committee).
● Roche (Currently Ongoing) (Products/Services: Contractor including contracted research).
● SeaStar Medical (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant).

Sandra E. Juul, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sangeeta Hingorani, MD,MPH: ● Omeros (Currently Ongoing) (Products/Services: Consultant).

David Askenazi, MD, MSPH: ● Baxter (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
● Bioporto (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
● Medtronic (Products/Services: Consultant).
● Nuwellis (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
● Seastar (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).